NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for CMML


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Findings from Catholic University broaden understanding of myelodysplastic syndrome
2009 SEP 28 ... with excess blasts in transformation, 19 patients; and chronic myelomanocytic leukemia (CMML), 4 patients) and an International Prognostic Scoring System (IPSS) rating of ...
Subject: Myelodysplastic Syndrome
Price: $3.00
*
National Hospital Organization reports research in demyelinating polyneuropathy
2009 OCT 5 ... herein the case of a 65-year-old Japanese woman with chronic myelomonocytic leukemia (CMML) accompanying chronic inflammatory demyelinating polyneuropathy (CIDP)," scientists ...
Subject: Demyelinating Polyneuropathy
Price: $3.00
*
New chronic myelomonocytic leukemia genetics study findings have been reported from Chang Gung Memorial Hospital, Department of Internal Medicine
2009 AUG 24 ... RUNX1 mutations have rarely been reported in chronic myelomonocytic leukemia (CMML)," scientists in Taipei, Taiwan report. "We examined RUNX1 mutations in ...
Subject: Chronic Myelomonocytic Leukemia Genetics
Price: $3.00
*
New chronic myelomonocytic leukemia research from INSERM outlined
2009 JAN 26 ... "Chronic myelomonocytic leukemia (CMML) is a hematological disease close to, but separate from both myeloproliferative ...
Subject: Chronic Myelomonocytic Leukemia
Price: $3.00
*
Onconova Therapeutics Announces Presentation of Nonclinical Data on Lead Compound ON 01910.Na and New Jak 2/Bcr-abl Inhibitors at AACR
2009 MAY 11 ... (CNL), atypical chronic myeloid leukemia (CML) and chronic myelomonocytic leukemia (CMML) at incidences of 50%, 20%, 20% and 3%, respectively. JAK2V617F has been found to confer ...
Subject: Onconova Therapeutics, Inc.
Price: $3.00
*
Reports on cancer findings from A.J. Dunbar and co-researchers provide new insights
2009 FEB 9 ... defect in myeloid malignancies, particularly in chronic myelomonocytic leukemia (CMML; 48%) and MDS/MPD-unclassifiable (38%). Furthermore, we show that mapping minimally ...
Subject: Cancer
Price: $3.00
*
Research on chronic myelomonocytic leukemia reported by M. Qubaja et al
2009 JUN 8 ... study of bone marrow biopsy (BMB) in chronic myelomonocytic leukemia (CMML) is often difficult and might benefit from an immunohistochemical approach. We ...
Subject: Chronic Myelomonocytic Leukemia
Price: $3.00
*
Research reports on leukemia from O. Abdelwahab and colleagues provide new insights
2009 AUG 24 ... TET2, and TET3 in myeloproliferative neoplasms (MPNs), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML)," scientists in the United States report. ...
Subject: Leukemia
Price: $3.00
*
Research results from A.M. Jankowska and colleagues update understanding of neoplasms
2009 AUG 3 ... showed most TET2 mutations were present in patients with MDS/MPN (58%), including CMML (6/17) or sAML (32%) evolved from MDS/MPN and typical MDS (10%), suggesting they may ...
Subject: Neoplasms
Price: $3.00
*
Researchers at Oregon Health & Science University publish new data on myeloid leukemia
2009 APR 6 ... HRAS in 329 acute myeloid leukemia (AML) patients, 32 chronic myelomonocytic leukemia (CMML) patients, and 96 healthy individuals. We detected 4 ''noncanonical'' point ...
Subject: Myeloid Leukemia
Price: $3.00
*
Researchers from University of Turin discuss findings in bone marrow
2009 NOV 9 ... According to a study from Turin, Italy, "Chronic myelomonocytic leukaemia (CMML) is a haematopoietic malignancy with heterogeneous clinical and morphological features. ...
Subject: Bone Marrow
Price: $3.00
*
Researchers from Zhejiang University report on findings in chronic myelomonocytic leukemia immunology
2009 OCT 5 ... leukemia chronic phase (CGL-CP), 39 cases of chronic myelomonocytic leukemia (CMML)." "In addition, we evaluated characteristics of BM trephine biopsies in ...
Subject: Chronic Myelomonocytic Leukemia Immunology
Price: $3.00
*
Studies from University of Minnesota update current data on myelodysplastic syndrome
2009 MAR 16 ... (RA), myelodysplastic syndrome-unclassifiable (MDS-U), chronic myelomonocytic leukemia (CMML), myelodysplastic/myeloproliferative disease (MDS/MPD), or myelodysplastic syndrome-not ...
Subject: Myelodysplastic Syndrome
Price: $3.00
*
The MDS Foundation Welcomes Availability of VIDAZA (Azacitidine) in the UK and Ireland
2009 MAR 16 ... of patients with intermediate-2 and higher-risk MDS, chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML with 20-30% blasts). As the first and ...
Subject: MDS Foundation
Price: $3.00
*
The MDS Foundation Welcomes Availability of VIDAZA Azacitidine in the UK and Ireland
2009 MAR 16 ... of patients with intermediate-2 and higher-risk MDS, chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML with 20-30% blasts). As the first and ...
Subject: MDS Foundation
Price: $3.00
*
VIDAZA Upgraded to Category 1 Based on Unprecedented Survival and Selected Preferred Treatment for Intermediate-2 and High-Risk Myelodysplastic Syndromes by the National Comprehensive Cancer Network NCCN in Its Clinical Practice Guideli
2009 AUG 17 ... with excess blasts in transformation (RAEB-T), and chronic myelomonocytic leukaemia (CMML). The more recent WHO classification system incorporates RAEB-T patients within the AML ...
Subject: Celgene Corporation
Price: $3.00
*
Reports on myelodysplastic syndrome findings from C. Ravoet and co-researchers provide new insights
2008 NOV 17 ... FAB/RAEB (n=10), RAEB-T (n=2), sAML (n=2) and chronic myelomonocytic leukaemia (CMML; n=2); WHO/RAEB-1 (n=4), RAEB-2 (n=5), AML (n=5), CMML ...
Subject: Myelodysplastic Syndrome
Price: $3.00
*
Research from Cornell University in the area of myelodysplastic syndrome published
2008 NOV 17 ... with advanced myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) were treated with a continuous oral dose of 200 -300mg of lonafarnib and were evaluated ...
Subject: Myelodysplastic Syndrome
Price: $3.00
*
Studies from University of Basel have provided new data on chronic myelomonocytic leukemia
2008 OCT 27 ... of a cytogenetic abnormality or overt dysplasia, chronic myelomonocytic leukemia (CMML) may be difficult to be distinguished from reactive monocytosis. We have previously ...
Subject: Chronic Myelomonocytic Leukemia
Price: $3.00
*
Study results from Baylor College of Medicine, College of Medicine update understanding of leukemia
2008 OCT 27 ... ineffective hematopoiesis, followed by transition to chronic myelomonocytic leukemia (CMML)-like myelodysplastic/myeloproliferative disorder, and then transformation to AML. The ...
Subject: Leukemia
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login